We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Valo Health’s Bioware Platform Shows Potential in Predicting Efficacy of Cardiac Devices
Valo Health’s Bioware Platform Shows Potential in Predicting Efficacy of Cardiac Devices
Valo Health announced positive results of a five-year collaboration with the FDA to study the potential of cardiac contractility modulation (CCM) to treat heart failure patients using human engineered cardiac tissues to assess the device’s safety.